Key result
Pituitary adrenocorticotropic hormone (ACTH) use in poliomyelitis is discussed in the context of host susceptibility and nonspecific defensive mechanisms, with no quantitative results reported.
Answers are grounded in this paper and cite their sources.
Should not change poliomyelitis management; leaves open ACTH effects on host susceptibility for prospective study.
Certain data about poliomyelitis suggest an unusual host-parasite relationship. Among these are the low incidence of paralysis, 1 less than 1 in 100 cases of poliomyelitis infection; the familial incidence, 2 constitutional factors 3 and endocrine imbalance theories 4 which have been advanced to explain susceptibility; excessive fatigue and chilling or exhaustion during the incubation period, which is frequently followed by severe paralysis, and the greater incidence of paralysis in pregnant women as compared with nonpregnant women. 5 The concept of latent immunization to various antigenic types of virus does not explain the epidemiologic patterns of the disease. 6 All these observations suggest that susceptibility or resistance to poliomyelitis involves nonspecific defensive mechanisms and, indirectly, that the host response is more important than the virulence of the virus in determining the course of infection. Rapid mobilization of bodily defensive mechanisms may limit the spread of infection in the usual nonparalytic
No takes yet. Share an insight, caveat, or question.
L.L. Coriell (1950) conducted a review in Poliomyelitis. Pituitary adrenocorticotropic hormone (ACTH) was evaluated. Pituitary adrenocorticotropic hormone (ACTH) use in poliomyelitis is discussed in the context of host susceptibility and nonspecific defensive mechanisms, with no quantitative results reported.
Synapse has enriched 10 related papers. Consider them for comparative context: